{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:00:06Z","timestamp":1781085606385,"version":"3.54.1"},"reference-count":39,"publisher":"Medknow","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Basic Clin Pharma"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4103\/0976-0105.183263","type":"journal-article","created":{"date-parts":[[2016,5,31]],"date-time":"2016-05-31T13:10:04Z","timestamp":1464700204000},"page":"80","source":"Crossref","is-referenced-by-count":23,"title":["Monitoring of adverse drug reactions in psychiatry outpatient department of a Secondary Care Hospital of Ras Al Khaimah, UAE"],"prefix":"10.4103","volume":"7","author":[{"given":"SathvikBelagodu","family":"Sridhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SuraSaad Faris","family":"Al-Thamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riadh","family":"Jabbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2581","reference":[{"key":"key-10.4103\/0976-0105.183263-1","first-page":"e33236","volume-title":"Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions - A meta-analysis","author":"Hakkarainen","year":"2012","journal-title":"PLoS One"},{"key":"key-10.4103\/0976-0105.183263-2","first-page":"1200","volume-title":"Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies","author":"Lazarou","year":"1998","journal-title":"JAMA"},{"key":"key-10.4103\/0976-0105.183263-3","first-page":"1858","volume-title":"National surveillance of emergency department visits for outpatient adverse drug events","author":"Budnitz","year":"2006","journal-title":"JAMA"},{"key":"key-10.4103\/0976-0105.183263-4","first-page":"46","volume-title":"Hospitalisations caused by adverse drug reactions (ADR): A meta-analysis of observational studies","author":"Beijer","year":"2002","journal-title":"Pharm World Sci"},{"key":"key-10.4103\/0976-0105.183263-5","first-page":"226","volume-title":"Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital","author":"Jose","year":"2006","journal-title":"Pharmacol Res"},{"key":"key-10.4103\/0976-0105.183263-6","first-page":"559","volume-title":"Cost of adverse drug reactions in a South Indian tertiary care teaching hospital","author":"Rajakannan","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"key-10.4103\/0976-0105.183263-7","first-page":"36","volume-title":"Adverse drug reaction monitoring in psychiatry out-patient department of an Indian teaching hospital","author":"Sengupta","year":"2011","journal-title":"Indian J Pharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0253-7613","issn-type":"print"},{"key":"key-10.4103\/0976-0105.183263-8","first-page":"911","volume-title":"Adverse effects of atypical antipsychotics: Differential risk and clinical implications","author":"Haddad","year":"2007","journal-title":"CNS Drugs"},{"key":"key-10.4103\/0976-0105.183263-9","first-page":"102","volume-title":"Adverse drug reaction monitoring in psychiatric outpatient department of a tertiary care hospital","author":"Prajapati","year":"2013","journal-title":"Natl J Integr Res Med"},{"key":"key-10.4103\/0976-0105.183263-10","first-page":"1131","volume-title":"Adverse drug reaction monitoring of antidepressants in the psychiatry outpatients department of a tertiary care teaching hospital","author":"Mishra","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"key-10.4103\/0976-0105.183263-11","first-page":"341","volume-title":"Adverse drug reaction profile at psychiatry out-patient department of a tertiary referral centre in Central India","author":"Solanke","year":"2013","journal-title":"Int J Basic Clin Pharmacol"},{"key":"key-10.4103\/0976-0105.183263-12","first-page":"158","volume-title":"Evaluation and analysis of adverse drug reactions of second generation antipsychotics in a psychiatry out-patient department","author":"Pahari","year":"2012","journal-title":"Int J Pharm Pharm Sci"},{"key":"key-10.4103\/0976-0105.183263-13","first-page":"819","volume-title":"Adverse drug reactions in hospitalized psychiatric patients","author":"Thomas","year":"2010","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/0976-0105.183263-14","first-page":"393","volume-title":"US adverse drug reaction surveillance 1989-1994","author":"Faich","year":"1996","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"key-10.4103\/0976-0105.183263-15","first-page":"239","volume-title":"A method for estimating the probability of adverse drug reactions","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"key-10.4103\/0976-0105.183263-16","unstructured":"The Use of the WHO-UMC System for Standardized Case Causality Assessment. Available from: http:\/\/www.WHO-UMC.org\/graphics\/4409.pdf. [Last accessed on 2012 Mar 12]."},{"key":"key-10.4103\/0976-0105.183263-17","first-page":"2229","volume-title":"Preventability and severity assessment in reporting adverse drug reactions","author":"Hartwig","year":"1992","journal-title":"Am J Hosp Pharm"},{"key":"key-10.4103\/0976-0105.183263-18","first-page":"538","volume-title":"Focusing on the preventability of adverse drug reactions","author":"Schumock","year":"1992","journal-title":"Hosp Pharm"},{"key":"key-10.4103\/0976-0105.183263-19","first-page":"49","volume-title":"Longitudinal study to monitor the adverse drug reactions in our psychiatric outpatient department of a tertiary care teaching hospital, Surindar nagar","author":"Shah","year":"2014","journal-title":"J Drug Deliv Ther"},{"key":"key-10.4103\/0976-0105.183263-20","first-page":"176","volume-title":"Adverse drug reaction monitoring in psychiatry out-patient department of a tertiary care hospital","author":"Sandiya","year":"2014","journal-title":"Glob J Pharmacol"},{"key":"key-10.4103\/0976-0105.183263-21","first-page":"19","volume-title":"Adverse drug reactions monitoring to various psychotropic drugs in psychiatry department of a tertiary care hospital, Chennai","author":"Nithya","year":"2013","journal-title":"J Pharm Biol Sci"},{"key":"key-10.4103\/0976-0105.183263-22","first-page":"470","volume-title":"Adverse drug reaction monitoring of antipsychotics, antidepressants and mood stabilisers in the psychiatric outpatient unit of a teaching hospital - A retrospective study","author":"Lahon","year":"2012","journal-title":"Int J Pharma Bio Sci"},{"key":"key-10.4103\/0976-0105.183263-23","first-page":"153","volume-title":"Analysis of adverse drug reactions of atypical antipsychotic drugs in psychiatry OPD","author":"Piparva","year":"2011","journal-title":"Indian J Psychol Med","ISSN":"https:\/\/id.crossref.org\/issn\/0253-7176","issn-type":"print"},{"key":"key-10.4103\/0976-0105.183263-24","first-page":"100","volume-title":"Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: A cross-sectional assessment of a primary health care database","author":"Sicras-Mainar","year":"2008","journal-title":"Eur Psychiatry"},{"key":"key-10.4103\/0976-0105.183263-25","first-page":"77","volume-title":"Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: Results of the EIRE study","author":"Bobes","year":"2003","journal-title":"Schizophr Res"},{"key":"key-10.4103\/0976-0105.183263-26","doi-asserted-by":"crossref","unstructured":"Taylor D, Paon C, Kapur S, editors. The Maudsley Prescribing Guidelines. 10 th ed. London: Informa Healthcare; 2009. p. 96-7.","DOI":"10.3109\/9780203092835"},{"key":"key-10.4103\/0976-0105.183263-27","doi-asserted-by":"crossref","unstructured":"Kim SH, Ivanova O, Abbasi FA, Lamendola CA, Reaven GM, Glick ID. Metabolic impact of switching antipsychotic therapy to aripiprazole after weight gain: A pilot study. J Clin Psychopharmacol 2007;27:365-8.","DOI":"10.1097\/JCP.0b013e3180a9076c"},{"key":"key-10.4103\/0976-0105.183263-28","first-page":"128","volume-title":"Adverse drug reactions in psychiatry outpatients: Clinical spectrum, causality and avoidability","author":"Jayanthi","year":"2013","journal-title":"J Chem Pharm Res"},{"key":"key-10.4103\/0976-0105.183263-29","first-page":"146","volume-title":"Cross-sectional study of prescribing patterns in chronic psychiatric patients living in sheltered housing facilities","author":"Schorr","year":"2008","journal-title":"Int J Clin Pharmacol Ther"},{"key":"key-10.4103\/0976-0105.183263-30","doi-asserted-by":"crossref","unstructured":"Taylor D, Paon C, Kapur S, editors. The Maudsley Prescribing Guidelines. 10 th ed. London: Informa Healthcare; 2009. p. 96-7, 202.","DOI":"10.3109\/9780203092835"},{"key":"key-10.4103\/0976-0105.183263-31","unstructured":"American Pharmacist Association. Drug Information Handbook. 21 st ed. Hudson, Ohio: Lexi-Comp, Inc.; 2011. p. 669."},{"key":"key-10.4103\/0976-0105.183263-32","unstructured":"American Pharmacist Association. Drug Information Handbook. 21 st ed. Hudson, Ohio: Lexi-Comp, Inc.; 2011. p. 433, 669, 1321."},{"key":"key-10.4103\/0976-0105.183263-33","first-page":"859","volume-title":"What happens with adverse events during 6 months of treatment with selective serotonin reuptake inhibitors?","author":"Demyttenaere","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"key-10.4103\/0976-0105.183263-34","first-page":"258","volume-title":"Who develops severe or fatal adverse drug reactions to selective serotonin reuptake inhibitors?","author":"Dalfen","year":"2001","journal-title":"Can J Psychiatry"},{"key":"key-10.4103\/0976-0105.183263-35","first-page":"200","volume-title":"The pharmacovigilance of psychoactive medications in Brazil","author":"Carlini","year":"2003","journal-title":"Rev Bras Psiquiatr"},{"key":"key-10.4103\/0976-0105.183263-36","first-page":"464","volume-title":"Med-psych drug-drug interactions update: An overview of psychotropic drug-drug interactions","author":"Sandson","year":"2005","journal-title":"Psychosomatics"},{"key":"key-10.4103\/0976-0105.183263-37","first-page":"931","volume-title":"Adverse drug reactions: A retrospective review of hospitalized patients at a state psychiatric hospital","author":"Iuppa","year":"2013","journal-title":"Hosp Pharm"},{"key":"key-10.4103\/0976-0105.183263-38","first-page":"83","volume-title":"Factors affecting the development of adverse drug reactions (Review article)","author":"Alomar","year":"2014","journal-title":"Saudi Pharm J"},{"key":"key-10.4103\/0976-0105.183263-39","first-page":"139","volume-title":"Tardive dyskinesia: Analysis of outpatients with schizophrenia from Africa and the Middle East, Asia, Central and Eastern Europe, and Latin America","author":"Kasper","year":"2006","journal-title":"Schizophr Res"}],"container-title":["Journal of Basic and Clinical Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T02:24:04Z","timestamp":1567995844000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jbclinpharm.org\/text.asp?2016\/7\/3\/80\/183263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"alternative-id":["183263"],"URL":"https:\/\/doi.org\/10.4103\/0976-0105.183263","relation":{},"ISSN":["0976-0105"],"issn-type":[{"value":"0976-0105","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}